Please login to the form below

Not currently logged in
Email:
Password:

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

The ADC has been recommended with doxorubicin, vinblastine and dacarbazine. Takeda has announced that the European Medicines Agency’s human medicines committee has recommended Adcetris (brentuximab vedotin) as part of a ... The CHMP’s recommendation

Latest news

More from news
Approximately 0 fully matching, plus 296 partially matching documents found.

Latest Intelligence

  • What are you doing here? Closing the gap with compelling healthcare communication What are you doing here? Closing the gap with compelling healthcare communication

    Here are the key takeaways:. Suboptimal decision-making by HCPs. More than 50% of all medicines are prescribed, dispensed or sold inappropriately and about 50% of patients do not take medicines ... correctly. From irrational use of medicines, clinical

  • The importance of medical affairs The importance of medical affairs

    Real-world evidence (RWE): the use of real-world data (RWD) and RWE is gaining prominence in healthcare decision-making. ... By bridging scientific knowledge, clinical practice and regulatory compliance, medical affairs contributes to the safe and

  • Setting up for success in a post-Brexit, post-pandemic Britain Setting up for success in a post-Brexit, post-pandemic Britain

    Similarly, long-term challenges around the licensing of medicines for use in the UK, as well as the expected additional workload and cost that this will entail for industry, on top ... With three COVID-19 vaccines approved for use in the UK at the time

  • Growing evidence supports the important role of biosimilars in healthcare Growing evidence supports the important role of biosimilars in healthcare

    Access to healthcare, including affordable medicines, remains a top concern across the US. ... This can help expand options for chronically ill patients and allow greater use of biologic medicines by providing more affordable access to individuals who,

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... Secondly, the revised Patents Act encourages the development of safe medicinal products for paediatric use.

More from intelligence
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest appointments

  • New hires at Bayer, Eisai and Accord Healthcare New hires at Bayer, Eisai and Accord Healthcare

    Prior to joining Accord, Grosso held a number of senior public and commercial roles, including the role of principal medicines management pharmacist at UCL Hospitals. ... Grosso is also a registered pharmacist, and has a long-standing interest in the

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....